17866 results
-
List item
Human medicine European public assessment report (EPAR): Veyvondi (updated)
vonicog alfa, von Willebrand Diseases
Date of authorisation: 31/08/2018,
, Revision: 2, Authorised, Last updated: 26/11/2020
-
List item
Human medicine European public assessment report (EPAR): Edistride (updated)
dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Date of authorisation: 09/11/2015, Revision: 14, Authorised, Last updated: 25/11/2020 -
List item
Human medicine European public assessment report (EPAR): Kaletra (updated)
lopinavir, ritonavir, HIV Infections
Date of authorisation: 19/03/2001, Revision: 55, Authorised, Last updated: 25/11/2020 -
List item
Human medicine European public assessment report (EPAR): Lyrica (updated)
pregabalin, Epilepsy, Anxiety Disorders, Neuralgia
Date of authorisation: 05/07/2004, Revision: 48, Authorised, Last updated: 30/11/2020 -
List item
Human medicine European public assessment report (EPAR): Mvabea (updated)
Recombinant Modified Vaccinia Ankara Bavarian Nordic Virus encoding the: Ebola virus Zaire (ZEBOV) Mayinga strain glycoprotein (GP); Ebola virus Sudan Gulu strain GP; Ebola virus Taï Forest strain nucleoprotein and the Marburg virus Musoke strain GP, Hemorrhagic Fever, Ebola
Date of authorisation: 01/07/2020,, 
, Authorised, Last updated: 24/11/2020
-
List item
Human medicine European public assessment report (EPAR): Lamzede (updated)
velmanase alfa, alpha-Mannosidosis
Date of authorisation: 23/03/2018,, 
, , Revision: 3, Authorised, Last updated: 24/11/2020
-
List item
Human medicine European public assessment report (EPAR): Emselex (updated)
darifenacin hydrobromide, Urinary Incontinence, Urge, Urinary Bladder, Overactive
Date of authorisation: 22/10/2004, Revision: 23, Authorised, Last updated: 24/11/2020 -
List item
Human medicine European public assessment report (EPAR): Copalia HCT (updated)
amlodipine, valsartan, hydrochlorothiazide, Hypertension
Date of authorisation: 03/11/2009, Revision: 17, Authorised, Last updated: 24/11/2020 -
List item
Human medicine European public assessment report (EPAR): Alofisel (updated)
darvadstrocel, Rectal Fistula
Date of authorisation: 23/03/2018,, , Revision: 5, Authorised, Last updated: 24/11/2020
-
List item
Human medicine European public assessment report (EPAR): Insuman (updated)
insulin human, Diabetes Mellitus
Date of authorisation: 21/02/1997, Revision: 30, Authorised, Last updated: 24/11/2020 -
List item
Human medicine European public assessment report (EPAR): Posaconazole Accord (updated)
posaconazole, Mycoses
Date of authorisation: 25/07/2019,
, Revision: 1, Authorised, Last updated: 24/11/2020
-
List item
Veterinary medicine European public assessment report (EPAR): Zulvac 8 Bovis (updated)
inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02, Cattle
Date of authorisation: 15/01/2010, Revision: 7, Withdrawn, Last updated: 24/11/2020 -
List item
Human medicine European public assessment report (EPAR): Zaltrap (updated)
aflibercept, Colorectal Neoplasms
Date of authorisation: 01/02/2013, Revision: 9, Authorised, Last updated: 23/11/2020 -
List item
Human medicine European public assessment report (EPAR): Orkambi (updated)
Lumacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 18/11/2015,, Revision: 23, Authorised, Last updated: 23/11/2020
-
List item
Human medicine European public assessment report (EPAR): Apidra (updated)
insulin glulisine, Diabetes Mellitus
Date of authorisation: 27/09/2004, Revision: 30, Authorised, Last updated: 23/11/2020 -
List item
Human medicine European public assessment report (EPAR): Docetaxel Teva (updated)
docetaxel, Head and Neck Neoplasms, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, Prostatic Neoplasms, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/01/2010,, Revision: 18, Authorised, Last updated: 23/11/2020
-
List item
Human medicine European public assessment report (EPAR): Skyrizi (updated)
Risankizumab, Psoriasis
Date of authorisation: 26/04/2019,, Revision: 4, Authorised, Last updated: 23/11/2020
-
List item
Human medicine European public assessment report (EPAR): Insulatard (updated)
insulin human, Diabetes Mellitus
Date of authorisation: 07/10/2002, Revision: 20, Authorised, Last updated: 23/11/2020 -
List item
Human medicine European public assessment report (EPAR): Vyndaqel (updated)
tafamidis, Amyloidosis
Date of authorisation: 16/11/2011,, , , Revision: 17, Authorised, Last updated: 23/11/2020
-
List item
Human medicine European public assessment report (EPAR): Yellox (updated)
bromfenac sodium sesquihydrate, Pain, Postoperative, Ophthalmologic Surgical Procedures
Date of authorisation: 18/05/2011, Revision: 10, Authorised, Last updated: 23/11/2020 -
List item
Human medicine European public assessment report (EPAR): Actelsar HCT (updated)
telmisartan, hydrochlorothiazide, Essential Hypertension
Date of authorisation: 13/03/2013,, Revision: 11, Authorised, Last updated: 23/11/2020
-
List item
Human medicine European public assessment report (EPAR): Ribavirin Teva (updated)
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 31/03/2009,, Revision: 14, Authorised, Last updated: 23/11/2020
-
List item
Human medicine European public assessment report (EPAR): NovoRapid (updated)
insulin aspart, Diabetes Mellitus
Date of authorisation: 07/09/1999, Revision: 31, Authorised, Last updated: 23/11/2020 -
List item
Human medicine European public assessment report (EPAR): Ribavirin Mylan (previously Ribavirin Three Rivers) (updated)
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 10/06/2010,, Revision: 10, Withdrawn, Last updated: 23/11/2020
-
List item
Veterinary medicine European public assessment report (EPAR): ProteqFlu (updated)
Vcp 2242 virus / Vcp1529 virus / Vcp1533 virus / vCP3011 virus, Horses
Date of authorisation: 06/03/2003, Revision: 14, Authorised, Last updated: 23/11/2020